[-] Show simple item record

dc.contributor.advisorKoulen, Petereng
dc.contributor.authorGrillo, Michael Anthonyeng
dc.date.issued2013eng
dc.date.submitted2013 Spring
dc.descriptionA dissertation in Cell Biology and Biophysics and Molecular Biology and Biochemistryeng
dc.descriptionIncludes bibliographical references (pages 92-105)eng
dc.description.abstractCalsenilin is calcium (Ca2+) ion Ca2+ binding protein found in the nucleus, plasma membrane, and endoplasmic reticulum of neuronal cells. Calsenilin was first found to interact with two proteins involved in early-onset familial Alzheimer disease (AD), presenilin 1 and presenilin 2. Several studies have shown overexpression of calsenilin to alter Ca2+ signaling and cell viability in several neuronal cell models of AD. In this study, we show that calsenilin directly interacts with the ryanodine receptor (RyR) modulating Ca2+ release from this intracellular Ca2+-activated Ca2+ release channel. Co-expression, co-localization, and protein-protein interaction of calsenilin and RyR in primary neurons and in central nervous system tissue were determined using immunoblotting, immunohistochemistry and co-immunoprecipitation. Mechanisms of intracellular Ca2+- signaling controlled by the interaction of calsenilin and RyR, including changes in the release of Ca2+ from intracellular stores, were measured with single channel electrophysiology and live-cell optical imaging techniques. Immunohistochemical studies showed a high degree of co-localization between calsenilin and the RyR in neurons of the central nervous system. Additionally, iv successful immunoprecipitation of a RyR-calsenilin protein complex from brain tissue provided evidence of a functional interaction. Using electrophysiological and Ca2+ imaging techniques the modulatory effects of calsenilin on Ca2+ release in a single RyR channel or in a cellular system with a population of RyR channels, respectively, whereby RyR-mediated intracellular Ca2+ release by calsenilin was determined under physiological and pathophysiological intracellular Ca2+ concentrations. Calsenilin directly interacts with the RyR, modulating Ca2+ induced Ca2+ release (CICR) pathways in neuronal cells. Further characterization of this interaction and its pharmacological and molecular biological control could provide insight into altered Ca2+ signaling in neurodegenerative and other diseases controlled by CICR and aid in developing novel alternative therapies using these newly identified mechanisms as targets.eng
dc.description.tableofcontentsIntroduction -- Materials and methods -- Results -- Discussion -- References -- Vitaeng
dc.identifier.urihttps://hdl.handle.net/10355/45498eng
dc.subjectAlzheimer's Diseaseeng
dc.subjectCalciumeng
dc.subjectCalsenilineng
dc.subjectRyanodineeng
dc.subject.lcshAlzheimer's diseaseeng
dc.subject.lcshCalcium -- Physiological effecteng
dc.titleModulation of neuronal ryanodine receptor-mediated calcium signaling by calsenilineng
dc.typeThesiseng
thesis.degree.disciplineCell Biology and Biophysics (UMKC)eng
thesis.degree.disciplineMolecular Biology and Biochemistry (UMKC)eng
thesis.degree.grantorUniversity of Missouri--Kansas Cityeng
thesis.degree.levelDoctoraleng
thesis.degree.namePh.D.eng


Files in this item

[PDF]

This item appears in the following Collection(s)

[-] Show simple item record